JG
HGEN

Jefferies Group’s HUMANIGEN, INC. HGEN Stock Holding History

Jefferies Group’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-402,938
Closed -$7.7M – 2098
2021
Q1 		$7.7M Buy
+402,938
New +$7.35M 0.07% 255

Other funds holding HGEN

VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jefferies Group's HGEN Position: Q2 2021 in Review

Jefferies Group sold out of HUMANIGEN, INC. (HGEN) in Q2 2021, closing a stake of 402,938 shares — an estimated $7.7M sold.

Jefferies Group first reported a position in HGEN in Q1 2021 and held it in 1 quarter. The position peaked at $7.7M in Q1 2021. 92 funds tracked by Wall St. Rank hold HGEN as of Q2 2021.

  • Jefferies Group reported no remaining HUMANIGEN, INC. position as of Q2 2021 after selling out during the quarter.
  • Jefferies Group sold 402,938 HUMANIGEN, INC. shares in Q2 2021, an estimated $7.7M.
  • Jefferies Group first reported a position in HUMANIGEN, INC. in Q1 2021 and held it in 1 quarter.
  • Jefferies Group's HUMANIGEN, INC. position peaked at $7.7M in Q1 2021.
  • 92 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q2 2021.

Based on Jefferies Group's 13F filing for Q2 2021, filed 16 Aug 2021.